These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Immuno-epidemiological investigation of recurrent spontaneous abortion]. Li D, Zhu Y, Wang M. Zhonghua Yi Xue Za Zhi; 1998 Feb; 78(2):94-7. PubMed ID: 10923415 [Abstract] [Full Text] [Related]
3. Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion. Pandey MK, Agrawal S. Int Immunopharmacol; 2004 Feb; 4(2):289-98. PubMed ID: 14996420 [Abstract] [Full Text] [Related]
4. Immunological characteristics of nonpregnant women with unexplained recurrent spontaneous abortion who underwent paternal lymphocytes immunization. Malinowski A, Wilczynski J, Zeman K, Glowacka E, Kolasa D, Szpakowski A, Oszukowski P, Szpakowski M. Zentralbl Gynakol; 1998 Feb; 120(10):493-502. PubMed ID: 9823650 [Abstract] [Full Text] [Related]
5. Analysis of anti-lymphocyte antibodies by flow cytometry or microlymphocytotoxicity in women with recurrent spontaneous abortions immunized with paternal leukocytes. Gilman-Sachs A, Luo SP, Beer AE, Beaman KD. J Clin Lab Immunol; 1989 Oct; 30(2):53-9. PubMed ID: 2534916 [Abstract] [Full Text] [Related]
11. [Study on positive rate of blocking antibody in women with recurrent spontaneous abortion administered by route and frequency of paternal lymphocyte immunotherapy]. Yu HL, Deng XH, Chao L, Chen C, Han YL. Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):903-6. PubMed ID: 24495682 [Abstract] [Full Text] [Related]
13. Pregnancy and neonatal outcomes in unexplained recurrent/habitual aborters treated by allogenic leukocyte immunization. Tanaka T, Umesaki N, Maeda K, Miyama M, Ogita S. Osaka City Med J; 1997 Jun; 43(1):81-7. PubMed ID: 9343997 [Abstract] [Full Text] [Related]
14. Paternal leucocyte immunotherapy for recurrent pregnancy loss. Agrawal S, Kishore R. Natl Med J India; 1995 Jun; 8(3):121-3. PubMed ID: 7780352 [Abstract] [Full Text] [Related]
16. Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion. Pandey MK, Thakur S, Agrawal S. Arch Gynecol Obstet; 2004 Mar; 269(3):161-72. PubMed ID: 14652774 [Abstract] [Full Text] [Related]
18. Cell-surface CD200 may predict efficacy of paternal mononuclear leukocyte immunotherapy in treatment of human recurrent pregnancy loss. Clark DA. Am J Reprod Immunol; 2009 Jan; 61(1):75-84. PubMed ID: 19086995 [Abstract] [Full Text] [Related]
19. Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion. Khonina NA, Broitman EV, Shevela EY, Pasman NM, Chernykh ER. Arch Gynecol Obstet; 2013 Oct; 288(4):933-7. PubMed ID: 23558562 [Abstract] [Full Text] [Related]
20. [Passive immunotherapy with polyvalent immunoglobulins in women with habitual abortions]. Mueller-Eckhardt G, Heine O, Turba H, Berghöfer A, Neppert J, Künzel W, Mueller-Eckhardt C. Beitr Infusionsther; 1990 Oct; 26():298-301. PubMed ID: 1703857 [Abstract] [Full Text] [Related] Page: [Next] [New Search]